Atlas Trials

Study of Imatinib Mesylate in Neurofibromatosis Type I Patients Aged 2 to 21 With Plexiform Neurofibromas

Clinical trial NCT02177825 · TERMINATED

Trial details

NCT number
NCT02177825
Sponsor
St. Justine's Hospital
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Plexiform Neurofibromas
Start date
2014-06-01
Primary completion
2019-03-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.